Anticancer platinum-based complexes with non-classical structures

被引:39
|
作者
Cai, Linxiang [1 ]
Yu, Congtao [1 ]
Ba, Linkui [1 ]
Liu, Qinghua [1 ]
Qian, Yunxu [1 ]
Yang, Bo [1 ]
Gao, Chuanzhu [1 ]
机构
[1] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming 650500, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
anticancer; drug delivery; multinuclear; non-classical; platinum; ANTITUMOR-ACTIVITY; IN-VITRO; METAL-COMPLEXES; DNA-BINDING; MONOFUNCTIONAL ADDUCTS; BIOLOGICAL EVALUATION; APOPTOSIS INDUCTION; DRUG CANDIDATES; CANCER-CELLS; TUMOR-CELLS;
D O I
10.1002/aoc.4228
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Although classical platinum drugs such as cisplatin, carboplatin and oxaliplatin play a vitally important role in cancer treatment, nonselective distribution of platinum drugs in normal and tumor cells can induce serious gastrointestinal reaction, nephrotoxicity, ototoxicity, neurotoxicity and cross resistance, limiting their applications. Over the past few years, a great number of platinum complexes of non-classical structures have been extensively investigated and evaluated in vitro and in vivo, some of them exhibiting considerable activity. In this review, platinum-based complexes with non-classical structures which have anticancer potential are described and several representative examples are discussed with their mechanism of action.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] A chemical perspective on the clinical use of platinum-based anticancer drugs
    Alassadi, Shoohb
    Pisani, Michelle J.
    Wheate, Nial J.
    DALTON TRANSACTIONS, 2022, 51 (29) : 10835 - 10846
  • [32] Drug transporters of platinum-based anticancer agents and their clinical significance
    Burger, Herman
    Loos, Walter J.
    Eechoute, Karel
    Verweij, Jaap
    Mathijssen, Ron H. J.
    Wiemer, Erik A. C.
    DRUG RESISTANCE UPDATES, 2011, 14 (01) : 22 - 34
  • [33] Targeted Drug Delivery System for Platinum-based Anticancer Drugs
    Gao, Chuanzhu
    Zhang, Yan
    Chen, Ji
    Wang, Tianshuai
    Qian, Yunxu
    Yang, Bo
    Dong, Peng
    Zhang, Yingjie
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2016, 16 (11) : 872 - 891
  • [34] Lipid, polymeric, inorganic-based drug delivery applications for platinum-based anticancer drugs
    Boztepe, Tugce
    Castro, Guillermo R.
    Leon, Ignacio E.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 605
  • [35] Platinum-Based Agents for Individualized Cancer Treatment
    Chen, X.
    Wu, Y.
    Dong, H.
    Zhang, C-Y
    Zhang, Y.
    CURRENT MOLECULAR MEDICINE, 2013, 13 (10) : 1603 - 1612
  • [36] Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands
    Starha, Pavel S.
    Krikavova, Radka
    COORDINATION CHEMISTRY REVIEWS, 2024, 501
  • [37] Induction of immunogenic cell death by novel platinum-based anticancer agents
    Chang, Xingyu
    Bian, Mianli
    Liu, Lijuan
    Yang, Jiaqi
    Yang, Zhibin
    Wang, Zhaoran
    Lu, Yunlong
    Liu, Wukun
    PHARMACOLOGICAL RESEARCH, 2023, 187
  • [38] Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action
    Dai, Ziwen
    Wang, Zhigang
    MOLECULES, 2020, 25 (21):
  • [39] Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action
    Khoury, Aleen
    Deo, Krishant M.
    Aldrich-Wright, Janice R.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2020, 207
  • [40] Inorganic Nano-Targeted Drugs Delivery System and Its Application of Platinum-Based Anticancer Drugs
    Chen, Ji
    Gao, Chuanzhu
    Zhang, Yan
    Wang, Tianshuai
    Qian, Yunxu
    Yang, Bo
    Dong, Peng
    Zhang, Yingjie
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2017, 17 (01) : 1 - 17